High intakes of choline and betaine reduce breast cancer mortality in a population‐based study
Open Access
- 27 July 2009
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 23 (11) , 4022-4028
Abstract
Choline and betaine provide methyl groups for one‐carbon metabolism. Humans obtain these nutrients from a wide range of foods. Betaine can also be synthesized endogenously from its precursor, choline. Although animal studies have implied a causal relationship between choline deficiency and carcinogenesis, the role of these two nutrients in human carcinogenesis and tumor progression is not well understood. We investigated the associations of dietary intakes of choline and betaine and breast cancer risk and mortality in the population‐based Long Island Breast Cancer Study Project. Among the 1508 case‐group women, 308 (20.2%) deaths occurred, among whom 164 (53.2%) died of breast cancer by December 31, 2005. There was an indication that a higher intake of free choline was associated with reduced risk of breast cancer ( P trend =0.04). Higher intakes of betaine, phosphocholine, and free choline were associated with reduced all‐cause as well as breast cancer‐specific mortality in a dose‐dependent fashion. We also explored associations of polymorphisms of three key choline‐ and betaine‐metabolizing genes and breast cancer mortality. The betaine‐homocysteine methyltransferase gene ( BHMT ) rs3733890 polymorphism was associated with reduced breast cancer‐specific mortality (hazard ratio, 0.64;95% confidence interval, 0.42–0.97). Our study supports the important roles of choline and betaine in breast carcinogenesis. It suggests that high intake of these nutrients may be a promising strategy to prevent the development of breast cancer and to reduce its mortality.—Xu, X., Gammon, M. D., Zeisal, S. H., Bradshaw, P. T., Wetmur, J. G., Teitelbaum, S. L., Neugut, A. I., Santella, R. M., Chen, J. High intakes of choline and betaine reduce breast cancer mortality in a population‐based study. FASEB J. 23, 4022–4028 (2009). www.fasebj.orgKeywords
Funding Information
- National Institutes of Health (CA109753, DK55865)
- U.S. Department of War (BC031746)
- National Cancer Institute
- National Institute of Environmental Health Sciences (UO1CA/ES66572, UO1CA66572, P30ES009089, P30ES10126)
This publication has 33 references indexed in Scilit:
- The methylenetetrahydrofolate reductase C677T mutation induces cell‐specific changes in genomic DNA methylation and uracil misincorporation: A possible molecular basis for the site‐specific cancer risk modificationInternational Journal of Cancer, 2009
- Raising gestational choline intake alters gene expression in DMBA‐evoked mammary tumors and prolongs survivalThe FASEB Journal, 2008
- Choline metabolism and risk of breast cancer in a population‐based studyThe FASEB Journal, 2008
- Dietary Choline and Betaine and the Risk of Distal Colorectal Adenoma in WomenJNCI: Journal of the National Cancer Institute, 2007
- Betaine: a key modulator of one-carbon metabolism and homocysteine statusClinical Chemistry and Laboratory Medicine (CCLM), 2005
- Homocysteine‐betaine interactions in a murine model of 5,10‐methylenetetrahydrofolate reductase deficiencyThe FASEB Journal, 2003
- DNA methylation and breast carcinogenesisOncogene, 2002
- Effects of prolonged (1 year) choline deficiency and subsequent re-feeding of choline on 1,2-sn-diradylglycerol, fatty acids and protein kinase C in rat liverCarcinogenesis, 1995
- Procarbazine carcinogenicity in methotrexate-treated or lipotrope-deficient male ratsCarcinogenesis, 1990
- The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogensCarcinogenesis, 1984